| Seth Klarman, Baupost Group (Bloomberg) |
Famed value investor Seth Klarman’s Baupost Group is exploring a new investing theme, building a portfolio of fledgling pharmaceutical companies.
| Seth Klarman, Baupost Group (Bloomberg) |
Famed value investor Seth Klarman’s Baupost Group is exploring a new investing theme, building a portfolio of fledgling pharmaceutical companies.
To continue reading, subscribe now to Premium Journalism. Already a subscriber? login.
